KAN On Other Exchanges
text size: T | T
Back to Snapshot
Company Description

Contact Info

Karolinska Institutet Science Park

Banvaktsvägen 22

Solna, 171 48


Phone: 46 8 50 12 60 80


Kancera AB, a biotechnology company, engages in the development and sale of pharmaceutical drug candidates in Sweden. The company develops drugs for the treatment of leukemia and solid tumors based on blocking survival signals in the cancer cell and on preventing adaptation of the cancer’s metabolism. Its pharmaceutical development projects include ROR inhibitors that reprogram the cancer cells, which are drug candidates for treatment of leukemia and solid tumors; PFKFB inhibitors for reducing cancer’s energy supply from glucose to solid tumors; HDAC6 inhibitors that are aimed to neutralize blood cancer by controlling the cancer cell genome; and AZD8797, fractalkine inhibitor for stopping the tumor growth and relieve severe pain, as well as small molecule inhibitors of epigenetic processes in parasites for the development of new treatments, including malaria and schistosomiasis. The company’s customers include pharmaceutical and biotechnology companies. Kancera AB was founded in 2010 and is based in Solna, Sweden.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

KAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KAN.
View Industry Companies

Industry Analysis


Industry Average

Valuation KAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 948.0x
Price/Book 5.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 916.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KANCERA AB, please visit www.kancera.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.